NDC 62064-122 – Trogarzo
Ibalizumab 150 mg/mL · Injection, Solution · Intravenous
Product NDC62064-122
Product details
- Brand name
- Trogarzo
- Generic name
- Ibalizumab
- Labeler
- Theratechnologies Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761065
- Marketed since
- April 20, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD4-directed Blocking Antibody; Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
Active ingredients
- Ibalizumab 150 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62064-122-02 | 2 VIAL, SINGLE-USE in 1 CARTON (62064-122-02) / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01) | Apr 20, 2018 |